These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study. Chapman ND, Grillage MG, Mazumder R, Atkinson SN. Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997 [Abstract] [Full Text] [Related]
6. Mebeverine in patients with the irritable colon syndrome: double blind study. Tasman-Jones C. N Z Med J; 1973 Apr; 77(491):232-5. PubMed ID: 4581721 [No Abstract] [Full Text] [Related]
7. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome. Van Outryve M, Mayeur S, Meeus MA, Rosillon D, Hendrickx B, Ceuppens M. J Clin Pharm Ther; 1995 Oct; 20(5):277-82. PubMed ID: 8576295 [Abstract] [Full Text] [Related]
14. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome. Arthurs Y, Fielding JF. Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924 [No Abstract] [Full Text] [Related]
16. Mebeverine alters small bowel motility in irritable bowel syndrome. Evans PR, Bak YT, Kellow JE. Aliment Pharmacol Ther; 1996 Oct; 10(5):787-93. PubMed ID: 8899088 [Abstract] [Full Text] [Related]
17. A randomised, double-blind study of mebeverine versus dicyclomine in the treatment of functional abdominal pain in young adults. Grillage MG, Nankani JN, Atkinson SN, Prescott P. Br J Clin Pract; 1990 May; 44(5):176-9. PubMed ID: 2202405 [No Abstract] [Full Text] [Related]